Happy to have contributed to this new publication in Alzheimer’s Research & Therapy shedding light on NFL and GFAP as potential biomarkers for cerebrovascular amyloid angiopathy (CAA)

📰doi.org/10.1186/s13195…

#diagnostics #biomarkers #CAA #GFAP #NFL

Today on #WorldParkinsonsDay , we want to raise awareness for #ParkinsonsDisease 💙
We are determined to continue developing novel fluid biomarker assays for early diagnosis and providing valuable information in clinical trials 🧠👨‍🔬 #ParkinsonsAwareness

ABOARD joins forces with over 30 partners including ADx NeuroSciences
ABOARD's mission is to kick start tailor-made treatment (personalized medicine) for #Alzheimers , by preparing for effective, patient-directed diagnosis, prediction and prevention.

#BrainAwarenessWeek2024

📢Join the Fluid biomarkers and imaging session 2 at #ADPD2024 where Steffi De Meyer from #LAMON_KUL will talk about associations of plasma synaptic biomarkers VAMP2, SNAP25 and GFAP, pTau181 & NfL with synaptic imaging in non-demented elderly💉🧓☢
#ADxInside KU Leuven

Another insightful day at #ADPD2024 !
Grab a☕️and visit our posters on:
🔬the performance of our in-house pS129 synuclein prototype assay
🧠the distinct core and synaptic CSF biomarker profiles & cognitive trajectories investigated in #alzheimers patients with a history of TBI

🔬 Curious about innovational research? Explore our new prototype immunoassay for alpha-specific GFAP and discover the first clinical validation of the N-terminal GFAP ELISA assay! 🧪🧠 Visit Laure’s poster today at #ADPD2024 . 📊👩‍🔬

Meet us at #ADPD2024 for exciting data on our novel prototypes for GFAP & pS129 alpha-synuclein as well as the evaluation of associations of ADx' synaptic biomarkers with synaptic/MRI imaging & cognitive trajectories in patients with #Alzheimer and #TBI .
adxneurosciences.com/adx-will-atten…

🚨 Paper alert Journal of Neurochemistry
Results from a new collaboration showing that a complete panel of Aβ species in CSF can be used to differentiated CAA from controls and AD-like subjects with high accuracy.
👉doi.org/10.1111/jnc.16…

#Biomarkers #Amyloid #Alzheimer #Diagnosis

Happy to share our new manuscript in Alzheimer’s Research & Therapy
🔬We show that synaptic biomarkers (NPTX2, SNAP25 and Ng) in CSF can be used to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders & #alzheimers

👉doi.org/10.1186/s13195…

📢 We are looking for an Administrative Logistics Coordinator to join us!

Are you:
📦Experienced in logistic & administrative processes
💻Able to work independently & accurately
💡An organizational talent with good communicational skills (EN & NL)

👉 flanders.bio/en/vacancies/a…

📢 We are looking for a scientist to expand our in-house service testing and reagent business activity!

This includes production of immunoassay reagents, process and product quality control steps and analytical validation of the assays.

👉 Apply now: flanders.bio/en/vacancies/s…

May 2024 be adorned with remarkable milestones and countless successes✨

We're grateful for your continued support & remain dedicated to deliver high-quality biomarkers and immunoassays for neurodegenerative disease🧠

Warmest wishes for a joyous holiday season🥂

📢Excited to announce that we moved into a new lab & office space in the Fujirebio Europe Headquarters.

We’re thrilled about the possibilities that lie ahead in our modern & spacious environment to support our growth!

🙏Thank you to every helping hand that made it happen

🚨We’ve developed an accurate assay for the synaptic biomarker VAMP-2 in collaboration with Sant Pau Memory Unit

We observed CSF VAMP-2 changes early in the #Alzheimers clinical continuum & correlations with worse performance across 5 cognitive domains

👉pubmed.ncbi.nlm.nih.gov/37898760/

Visit Charlotte's poster at #CTAD23 to learn more about our improved ELISA for VAMP2, an early biomarker for synaptic damage in #Alzheimers and other neurological diseases.

Proud of our collaboration with AXON Neuroscience, don’t miss out on Norbert Zilka’s presentation today (6:35pm) at #CTAD23

#ADxInside

Happy to be part of this collaborative effort MIRIADE 🙌

Our paper reviews the value of a selection of available technologies for discovery and implementation of biomarkers in research & clinics.

👉sciencedirect.com/science/articl…

#neurodegeneration #ADxInside #biomarkers

It's International Alzheimer's Day, let's unite to raise awareness and support the 55 million+ people living with Alzheimer's and their families. Together, we can make a difference in the fight against this disease.💜 #AlzheimersAwareness #WorldAlzheimersDay #AlzheimersDisease

It was great seeing you all at #AAIC23 , take a look at our #recap ! 👇

Congratulations to all our presenters! 👏

👉 Curious to see our posters about our Lumipulse G pTau217/181 and GFAP assays?! Check them out and scan the QR-code.

#AlzheimersDisease #biomarkers

📢 Visiting #AAIC2023 ? 📢
🧠 Join us at today’s poster session and visit Jeroen to gain insight on the performance of plasma pTau181 and pTau217 measured with fully automated LUMIPULSE G prototype immunoassays 🧠